Literature DB >> 13995245

Antibody formation. IV. Formation of rapidly and slowly sedimenting antibodies and immunological memory to bacteriophage phi-X 174.

J W UHR, M S FINKELSTEIN.   

Abstract

Injection of a sufficient dose of bacteriophage phiX 174 into guinea pigs results in the formation of rapidly sedimenting antibody molecules (19S), and later, slowly sedimenting molecules (7S). Above a threshold dose of antigen, the relative rate of 19S formation is maximal and dose-independent; below this dose, slower relative rates are obtained. The time for doubling the serum 19S level is as short as 6 to 8 hours, suggesting that the absolute rate of antibody formation per cell is increasing in addition to proliferation of antibody-producing cells. Synthesis of 19S after injection of 10(10) phiX virtually ceases at 10 days after which 19S antibody activity disappears from the circulation with a half-life of approximately 24 hours. A second injection of phiX on day 5 or 9 prolongs 19S synthesis, indicating that antigen not only can regulate the relative rate, but also is essential for continued synthesis of 19S. 19S synthesis is also prolonged in guinea pigs by injection of phiX with endotoxin or by 400 r whole body x-irradiation 24 hours after injection of phage into rabbits. The primary 7S response is not detected until approximately 1 week after immunization and relative rates are antigen-dependent. Primary 7S synthesis can continue for many months and leads to preparation for a secondary antibody response (immunological memory) during which only 7S is detected. In contrast, in animals that form precipitating 19S without detectable 7S, a second injection of phage 1 month later results in a second 19S response which closely resembles the first. These findings have led to the suggestion that formation of 19S does not lead to persisting immunological memory.

Entities:  

Keywords:  ANTIBODY FORMATION; COLIPHAGES

Mesh:

Substances:

Year:  1963        PMID: 13995245      PMCID: PMC2180453          DOI: 10.1084/jem.117.3.457

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  24 in total

1.  Effects of a nonspecific stimulation on tissue radiosensitivity during the course of antibody production.

Authors:  D STRAUCH; H S STENDER; H WINTER
Journal:  J Immunol       Date:  1959-04       Impact factor: 5.422

2.  The antibody response to bacteriophage phi-X 174 in newborn premature infants.

Authors:  J W UHR; J DANCIS; E C FRANKLIN; M S FINKELSTEIN; E W LEWIS
Journal:  J Clin Invest       Date:  1962-07       Impact factor: 14.808

3.  Autoradiographic observations of plasma cell formation.

Authors:  J C SCHOOLEY
Journal:  J Immunol       Date:  1961-03       Impact factor: 5.422

4.  Antibodies in the rabbit with different rates of metabolic decay.

Authors:  W H TALIAFERRO; D W TALMAGE
Journal:  J Infect Dis       Date:  1956 Jul-Aug       Impact factor: 5.226

5.  Effect of X rays on hemolysin formation following various immunization and irradiation procedures.

Authors:  W H TALIAFERRO; L G TALIAFERRO
Journal:  J Infect Dis       Date:  1954 Sep-Oct       Impact factor: 5.226

6.  The formation of macroglobulin antibodies. I. Studies on adult humans.

Authors:  J LOSPALLUTO; W MILLER; B DORWARD; C W FINK
Journal:  J Clin Invest       Date:  1962-07       Impact factor: 14.808

7.  The formation of macroglobulin antibodies. II. Studies on neonatal infants and older children.

Authors:  C W FINK; W E MILLER; B DORWARD; J LOSPALLUTO
Journal:  J Clin Invest       Date:  1962-07       Impact factor: 14.808

8.  Antibody formation. III. The primary and secondary antibody response to bacteriophage phi X 174 in guinea pigs.

Authors:  J W UHR; M S FINKELSTEIN; J B BAUMANN
Journal:  J Exp Med       Date:  1962-03-01       Impact factor: 14.307

9.  Autoradiographic studies on the immune response.I. The kinetics of plasma cell proliferation.

Authors:  G J NOSSAL; O MAKELA
Journal:  J Exp Med       Date:  1962-01-01       Impact factor: 14.307

10.  Physical properties of antibody to bovine serum albumin as demonstrated by hemagglutination.

Authors:  A A BENEDICT; R J BROWN; R AYENGAR
Journal:  J Exp Med       Date:  1962-01-01       Impact factor: 14.307

View more
  124 in total

1.  FURTHER SEROLOGICAL STUDIES ON THE RUBELLA SYNDROME.

Authors:  J A DUDGEON; N R BUTLER; S A PLOTKIN
Journal:  Br Med J       Date:  1964-07-18

2.  METABOLISM OF HUMAN GAMMA MACROGLOBULINS.

Authors:  W F BARTH; R D WOCHNER; T A WALDMANN; J L FAHEY
Journal:  J Clin Invest       Date:  1964-06       Impact factor: 14.808

3.  THE CELLULAR RESPONSE OF THE SPLEEN AND ITS RELATIONSHIP TO THE CIRCULATING 19S AND 7S ANTIBODY IN THE ANTIGENICALLY STIMULATED RABBIT.

Authors:  M D SCHOENBERG; J C RUPP; R D MOORE
Journal:  Br J Exp Pathol       Date:  1964-04

4.  ANTIBODIES AGAINST HAPTEN OF 7S AND MACROGLOBULIN TYPE IN CHICKENS.

Authors:  I RIHA; A SVICULIS
Journal:  Folia Microbiol (Praha)       Date:  1964-03       Impact factor: 2.099

5.  STIMULATING AND INHIBITING ANTIBODIES FOR BACTERIAL PENICILLINASE.

Authors:  M R POLLOCK
Journal:  Immunology       Date:  1964-11       Impact factor: 7.397

6.  NATURAL HAEMAGGLUTININS IN MICE: THEIR OCCURRENCE AND PROPERTIES.

Authors:  M S BROOKE
Journal:  Immunology       Date:  1965-04       Impact factor: 7.397

7.  STUDIES ON CHANGES IN THE QUALITY OF RABBIT-BOVINE SERUM ALBUMIN ANTIBODY FOLLOWING IMMUNIZATION.

Authors:  H M GREY
Journal:  Immunology       Date:  1964-01       Impact factor: 7.397

8.  Detection of antibodies of the IgM class in sera of patients recently infected with influenza viruses.

Authors:  Y I Buchner; R B Heath; J V Collins; J R Pattison
Journal:  J Clin Pathol       Date:  1976-05       Impact factor: 3.411

Review 9.  Targeting the B7 family of co-stimulatory molecules: successes and challenges.

Authors:  Joseph R Podojil; Stephen D Miller
Journal:  BioDrugs       Date:  2013-02       Impact factor: 5.807

10.  The effect of cross-reacting antigens on the tolerant state.

Authors:  B Cinader; J E St Rose; M Yoshimura
Journal:  J Exp Med       Date:  1967-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.